120 related articles for article (PubMed ID: 3020039)
21. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
22. Synergy is documented in vitro with low-dose recombinant tumor necrosis factor, cisplatin, and doxorubicin in ovarian cancer cells.
Bonavida B; Tsuchitani T; Zighelboim J; Berek JS
Gynecol Oncol; 1990 Sep; 38(3):333-9. PubMed ID: 2227544
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia.
Digel W; Stefanic M; Schöniger W; Buck C; Raghavachar A; Frickhofen N; Heimpel H; Porzsolt F
Blood; 1989 Apr; 73(5):1242-6. PubMed ID: 2539214
[TBL] [Abstract][Full Text] [Related]
24. Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses.
Scheurich P; Thoma B; Ucer U; Pfizenmaier K
J Immunol; 1987 Mar; 138(6):1786-90. PubMed ID: 3029221
[TBL] [Abstract][Full Text] [Related]
25. Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells.
Ostensen ME; Thiele DL; Lipsky PE
J Immunol; 1987 Jun; 138(12):4185-91. PubMed ID: 3108384
[TBL] [Abstract][Full Text] [Related]
26. Effects of tumor necrosis factor on sensitive and multidrug resistant human leukemia and myeloma cell lines.
Salmon SE; Soehnlen B; Dalton WS; Meltzer P; Scuderi P
Blood; 1989 Oct; 74(5):1723-7. PubMed ID: 2790197
[TBL] [Abstract][Full Text] [Related]
27. Studies on in vitro mechanisms of anti-tumor activity of the tumor necrosis factor alpha against human renal carcinoma cell line (KU-2).
Shibayama T
Keio J Med; 1989 Mar; 38(1):13-26. PubMed ID: 2716215
[TBL] [Abstract][Full Text] [Related]
28. Comparison of recombinant tumor necrosis factor and the monocyte-derived cytotoxic factor involved in monocyte-mediated cytotoxicity.
Nissen-Meyer J; Austgulen R; Espevik T
Cancer Res; 1987 May; 47(9):2251-8. PubMed ID: 3567918
[TBL] [Abstract][Full Text] [Related]
29. Role of the 75 kD- and 55 kD-receptors in tumour necrosis factor mediated cytotoxicity and its regulation by dexamethasone and by 1,25-dihydroxyvitamin D3 in U937 cells.
Chambaut-Guérin AM; Guerrier M; Thomopoulos P
Eur Cytokine Netw; 1993; 4(4):285-92. PubMed ID: 8268419
[TBL] [Abstract][Full Text] [Related]
30. Improvement of cytotoxicity of tumor necrosis factor (TNF) by increase in basicity of its N-terminal region.
Soma G; Kitahara N; Tsuji Y; Kato M; Oshima H; Gatanaga T; Inagawa H; Noguchi K; Tanabe Y; Mizuno D
Biochem Biophys Res Commun; 1987 Oct; 148(2):629-35. PubMed ID: 3318824
[TBL] [Abstract][Full Text] [Related]
31. Growth inhibition and cytotoxicity of tumor necrosis factor in L929 cells is enhanced by high cell density and inhibition of mRNA synthesis.
Kirstein M; Fiers W; Baglioni C
J Immunol; 1986 Oct; 137(7):2277-80. PubMed ID: 3760562
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Rickettsia conorii growth by recombinant tumor necrosis factor alpha: enhancement of inhibition by gamma interferon.
Manor E; Sarov I
Infect Immun; 1990 Jun; 58(6):1886-90. PubMed ID: 2111286
[TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor up-regulates gamma-interferon binding in a human carcinoma cell line.
Raitano AB; Korc M
J Biol Chem; 1990 Jun; 265(18):10466-72. PubMed ID: 2141333
[TBL] [Abstract][Full Text] [Related]
34. Influence of tumor necrosis factor-alpha on the modulation by interferon-gamma of HLA class II molecules in human thyroid cells and its effect on interferon-gamma binding.
Buscema M; Todd I; Deuss U; Hammond L; Mirakian R; Pujol-Borrell R; Bottazzo GF
J Clin Endocrinol Metab; 1989 Aug; 69(2):433-9. PubMed ID: 2502555
[TBL] [Abstract][Full Text] [Related]
35. Tumor necrosis factor inhibits MYC expression in HL-60 cells at the level of mRNA transcription.
Krönke M; Schlüter C; Pfizenmaier K
Proc Natl Acad Sci U S A; 1987 Jan; 84(2):469-73. PubMed ID: 3099296
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor and human hematopoiesis: I. Kinetics and diversity of human bone marrow cell response to recombinant tumor necrosis factor alpha in short-term suspension cultures in vitro.
Beran M; O'Brien S; Gutterman JU; McCredie KB
Hematol Pathol; 1988; 2(1):31-42. PubMed ID: 3266210
[TBL] [Abstract][Full Text] [Related]
37. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.
Lienard D; Ewalenko P; Delmotte JJ; Renard N; Lejeune FJ
J Clin Oncol; 1992 Jan; 10(1):52-60. PubMed ID: 1727926
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor-alpha augments pulmonary arterial transendothelial albumin flux in vitro.
Goldblum SE; Sun WL
Am J Physiol; 1990 Feb; 258(2 Pt 1):L57-67. PubMed ID: 1689552
[TBL] [Abstract][Full Text] [Related]
39. Induction of tumor necrosis factor-alpha and its receptors during differentiation in myeloid leukemic cells along the monocytic pathway. A possible regulatory mechanism for TNF-alpha production.
Michishita M; Yoshida Y; Uchino H; Nagata K
J Biol Chem; 1990 May; 265(15):8751-9. PubMed ID: 2160467
[TBL] [Abstract][Full Text] [Related]
40. Species specificity of human and murine tumor necrosis factor. A comparative study of tumor necrosis factor receptors.
Smith RA; Kirstein M; Fiers W; Baglioni C
J Biol Chem; 1986 Nov; 261(32):14871-4. PubMed ID: 3021754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
